A detailed history of Buckingham Capital Management, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Buckingham Capital Management, Inc. holds 12,071 shares of JNJ stock, worth $1.76 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
12,071
Previous 12,089 0.15%
Holding current value
$1.76 Million
Previous $1.77 Million 10.76%
% of portfolio
0.23%
Previous 0.21%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$145.48 - $167.38 $2,618 - $3,012
-18 Reduced 0.15%
12,071 $1.96 Million
Q2 2024

Jul 15, 2024

BUY
$144.38 - $157.78 $8,085 - $8,835
56 Added 0.47%
12,089 $1.77 Million
Q1 2024

Apr 10, 2024

BUY
$155.22 - $162.74 $69,538 - $72,907
448 Added 3.87%
12,033 $1.9 Million
Q4 2023

Feb 07, 2024

BUY
$145.6 - $158.88 $128,419 - $140,132
882 Added 8.24%
11,585 $1.82 Million
Q3 2023

Oct 13, 2023

BUY
$155.75 - $174.48 $101,393 - $113,586
651 Added 6.48%
10,703 $1.67 Million
Q2 2023

Jul 11, 2023

BUY
$154.35 - $166.11 $121,164 - $130,396
785 Added 8.47%
10,052 $1.66 Million
Q1 2023

Apr 11, 2023

BUY
$151.05 - $180.26 $237,601 - $283,548
1,573 Added 20.44%
9,267 $1.44 Million
Q4 2022

Jan 24, 2023

SELL
$160.2 - $179.79 $22,107 - $24,811
-138 Reduced 1.76%
7,694 $0
Q3 2022

Nov 10, 2022

BUY
$161.33 - $179.52 $40,655 - $45,239
252 Added 3.32%
7,832 $1.28 Million
Q2 2022

Aug 05, 2022

BUY
$168.19 - $186.01 $42,552 - $47,060
253 Added 3.45%
7,580 $1.35 Million
Q1 2022

May 06, 2022

SELL
$158.14 - $179.59 $43,330 - $49,207
-274 Reduced 3.6%
7,327 $1.3 Million
Q4 2021

Feb 07, 2022

BUY
$155.93 - $173.01 $4,210 - $4,671
27 Added 0.36%
7,601 $1.3 Million
Q3 2021

Nov 08, 2021

BUY
$161.5 - $179.47 $2,099 - $2,333
13 Added 0.17%
7,574 $1.22 Million
Q2 2021

Jul 27, 2021

SELL
$159.48 - $171.07 $25,516 - $27,371
-160 Reduced 2.07%
7,561 $1.25 Million
Q1 2021

May 04, 2021

BUY
$153.07 - $170.48 $55,105 - $61,372
360 Added 4.89%
7,721 $1.27 Million
Q4 2020

Feb 04, 2021

SELL
$137.11 - $157.38 $193,187 - $221,748
-1,409 Reduced 16.07%
7,361 $1.16 Million
Q3 2020

Nov 02, 2020

SELL
$140.38 - $153.83 $329,050 - $360,577
-2,344 Reduced 21.09%
8,770 $1.31 Million
Q2 2020

Jul 20, 2020

SELL
$128.81 - $155.51 $395,704 - $477,726
-3,072 Reduced 21.66%
11,114 $1.56 Million
Q1 2020

May 06, 2020

SELL
$111.14 - $153.99 $933,464 - $1.29 Million
-8,399 Reduced 37.19%
14,186 $1.86 Million
Q4 2019

Feb 13, 2020

SELL
$127.5 - $146.44 $715,402 - $821,674
-5,611 Reduced 19.9%
22,585 $3.29 Million
Q3 2019

Nov 12, 2019

SELL
$126.95 - $142.14 $844,217 - $945,230
-6,650 Reduced 19.08%
28,196 $3.65 Million
Q2 2019

Aug 09, 2019

SELL
$131.15 - $144.24 $1.67 Million - $1.84 Million
-12,734 Reduced 26.76%
34,846 $4.85 Million
Q1 2019

May 07, 2019

SELL
$125.72 - $139.79 $1.12 Million - $1.25 Million
-8,918 Reduced 15.78%
47,580 $6.65 Million
Q4 2018

Feb 04, 2019

SELL
$122.84 - $147.84 $212,021 - $255,171
-1,726 Reduced 2.96%
56,498 $7.29 Million
Q3 2018

Nov 20, 2018

SELL
$121.58 - $142.88 $389,663 - $457,930
-3,205 Reduced 5.22%
58,224 $8.05 Million
Q2 2018

Aug 10, 2018

BUY
$119.4 - $131.76 $32,357 - $35,706
271 Added 0.44%
61,429 $7.45 Million
Q1 2018

May 11, 2018

BUY
$125.1 - $148.14 $154,873 - $183,397
1,238 Added 2.07%
61,158 $7.84 Million
Q4 2017

Feb 13, 2018

BUY
$131.22 - $143.62 $97,890 - $107,140
746 Added 1.26%
59,920 $8.37 Million
Q3 2017

Nov 07, 2017

BUY
$129.47 - $135.38 $72,762 - $76,083
562 Added 0.96%
59,174 $7.69 Million
Q2 2017

Aug 10, 2017

BUY
N/A
58,612
58,612 $7.75 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Buckingham Capital Management, Inc. Portfolio

Follow Buckingham Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckingham Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Buckingham Capital Management, Inc. with notifications on news.